MoneyWorks4Me

Indoco Remedies - Quaterly Results

02 Nov 2021 Evaluate
The company witnessed a 17.99% growth in the revenue at Rs. 3865.90 millions for the quarter ended September 2021 as compared to Rs. 3276.50 millions during the year-ago period.Handsome Net Profit growth of 65.55% reported above the corresponding previous quarter figure of Rs. 415.70 millions to Rs. 251.10 millions.OP of the company witnessed a marginal growth to 873.30 millions from 607.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3865.90 3276.50 17.99 7730.80 6035.10 28.10 12403.00 11060.00 12.14
Other Income 10.10 5.20 94.23 18.70 7.80 139.74 31.20 24.30 28.40
PBIDT 873.30 607.00 43.87 1750.00 1098.20 59.35 2266.90 1257.70 80.24
Interest 30.60 58.90 -48.05 72.90 116.40 -37.37 222.20 262.50 -15.35
PBDT 842.70 548.10 53.75 1677.10 981.80 70.82 2044.70 995.20 105.46
Depreciation 194.60 185.70 4.79 416.90 377.00 10.58 731.20 708.10 3.26
PBT 648.10 362.40 78.84 1260.20 604.80 108.37 1313.50 287.10 357.51
TAX 232.40 111.30 108.81 448.40 181.40 147.19 389.60 44.60 773.54
Deferred Tax -30.80 -52.10 -40.88 -88.40 -97.30 -9.15 4.90 44.60 -89.01
PAT 415.70 251.10 65.55 811.80 423.40 91.73 923.90 242.50 280.99
Equity 184.30 184.30 0.00 184.30 184.30 0.00 184.30 184.30 0.00
PBIDTM(%) 22.59 18.53 21.94 22.64 18.20 24.40 18.28 11.37 60.72
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..